Our results from whole exome sequencing of serially transplanted mouse MLL/AF9-AML cells and confirmatory genetic and functional analyses of human MLL-AML provided insights into the molecular mechanism of leukemic progression in MLL-AML. This evidence concerns the gene KMT2A and acute myeloid leukemia.